Overview

Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers

Status:
Terminated

Trial end date:
2017-06-28

Target enrollment:

Participant gender:

Summary

This is an open-label, randomized, multi-part study to evaluate the relative oral bioavailability of a tablet formulation of AL-3778 (formerly NVR 3-778) administered under fasted and fed conditions (Parts 1 and 2) and the drug-drug interaction between AL-3778 and entecavir or tenofovir disoproxil fumarate (Part 3).

Phase:

Phase 1

Details

Lead Sponsor:

Alios Biopharma Inc.

Treatments:

Entecavir
Tenofovir